IL139825A0 - Novel cyclosporins - Google Patents

Novel cyclosporins

Info

Publication number
IL139825A0
IL139825A0 IL13982599A IL13982599A IL139825A0 IL 139825 A0 IL139825 A0 IL 139825A0 IL 13982599 A IL13982599 A IL 13982599A IL 13982599 A IL13982599 A IL 13982599A IL 139825 A0 IL139825 A0 IL 139825A0
Authority
IL
Israel
Prior art keywords
novel cyclosporins
cyclosporins
novel
pharmaceuticals
letters
Prior art date
Application number
IL13982599A
Other languages
English (en)
Original Assignee
Chem Ag C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Ag C filed Critical Chem Ag C
Publication of IL139825A0 publication Critical patent/IL139825A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13982599A 1998-06-12 1999-06-10 Novel cyclosporins IL139825A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110761 1998-06-12
PCT/EP1999/004012 WO1999065933A1 (en) 1998-06-12 1999-06-10 Novel cyclosporins

Publications (1)

Publication Number Publication Date
IL139825A0 true IL139825A0 (en) 2002-02-10

Family

ID=8232110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13982599A IL139825A0 (en) 1998-06-12 1999-06-10 Novel cyclosporins

Country Status (19)

Country Link
US (1) US6583265B1 (xx)
EP (1) EP1086124B1 (xx)
JP (1) JP4477777B2 (xx)
KR (1) KR20010052766A (xx)
CN (1) CN1205220C (xx)
AT (1) ATE254630T1 (xx)
AU (1) AU760168B2 (xx)
BR (1) BR9911160A (xx)
CA (1) CA2334730C (xx)
DE (1) DE69912952T2 (xx)
DK (1) DK1086124T3 (xx)
ES (1) ES2212583T3 (xx)
HU (1) HUP0102833A3 (xx)
IL (1) IL139825A0 (xx)
MX (1) MXPA00012218A (xx)
NO (1) NO20006282L (xx)
PL (1) PL344599A1 (xx)
PT (1) PT1086124E (xx)
WO (1) WO1999065933A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003529561A (ja) * 2000-02-08 2003-10-07 ワックス、マーティン、ビー 緑内障の治療法
US6784156B2 (en) 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
KR100465012B1 (ko) * 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US20030087813A1 (en) 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
KR20040039622A (ko) * 2002-11-04 2004-05-12 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US7012065B2 (en) 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
CN1964735A (zh) * 2004-04-08 2007-05-16 诺瓦提斯公司 环孢菌素用于治疗脑局部缺血以及脑和脊髓损伤的用途
KR101309409B1 (ko) * 2004-10-01 2013-09-23 싸이넥시스, 인크. Ｃ형 간염 바이러스 감염의 치료 및 예방을 위한 ３-에테르및 ３-티오에테르 치환된 시클로스포린 유도체
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
CA2623864C (en) * 2005-09-30 2014-12-16 Scynexis, Inc. Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection
EP1933859A2 (en) * 2005-09-30 2008-06-25 Scynexis, Inc. Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection
ES2361635T3 (es) 2006-05-19 2011-06-20 Scynexis, Inc. Ciclosporinas para el tratamiento y prevención de trastornos oculares.
EP2027761A1 (fr) * 2006-06-02 2009-02-25 Claude Annie Perrichon Gestion des electrons actifs
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
WO2008127613A1 (en) * 2007-04-11 2008-10-23 Scynexis, Inc. New pharmaceutical compositions
JP5820722B2 (ja) 2008-06-06 2015-11-24 スシネキス インク シクロスポリン類似体及びｈｃｖ感染の治療におけるその使用
US20090306033A1 (en) * 2008-06-06 2009-12-10 Keqiang Li Novel cyclic peptides
RU2521358C2 (ru) 2008-07-10 2014-06-27 Аллерган, Инк. Производные циклоспорина для лечения глазных и кожных заболеваний и состояний
JP5780969B2 (ja) 2008-12-31 2015-09-16 サイネクシス，インコーポレーテッド シクロスポリンａの誘導体
AU2010254316A1 (en) * 2009-05-27 2011-12-22 Allergan, Inc. Cyclosporin derivatives for treating inflammatory diseases and conditions
US20100305047A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
JP2013516424A (ja) 2009-12-30 2013-05-13 サイネクシス，インコーポレーテッド シクロスポリン類似体
US9217015B2 (en) 2010-07-16 2015-12-22 S&T Global Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
US9573978B2 (en) 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
BR112013008749A2 (pt) 2010-10-12 2019-09-24 Allergan Inc análogos de ciclosporina
AU2011316690C1 (en) 2010-10-12 2017-01-19 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
WO2012079172A1 (en) 2010-12-15 2012-06-21 Isotechnika Pharma Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技（上海）有限公司 环孢菌素类似物及其用途
US20230173017A1 (en) * 2019-10-12 2023-06-08 Farsight Medical Techology (Shanghai) Co., Ltd. Treatment and prevention of nephrotoxin-induced kidney injuries
CA3172535A1 (en) 2020-03-26 2021-09-30 Ching-Pong Mak Cyclophilin inhibitors and uses thereof
CN113694177B (zh) * 2020-04-15 2022-06-17 睿诺医疗科技（上海）有限公司 器官损伤的预防和治疗
GB202207348D0 (en) 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
DE59608274D1 (de) * 1995-07-17 2002-01-03 Chem Ag Binningen C Cyclosporin-derivate mit anti-hiv-wirkung
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757520B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PT1086124E (pt) 2004-04-30
AU760168B2 (en) 2003-05-08
BR9911160A (pt) 2001-04-03
NO20006282D0 (no) 2000-12-11
CN1305493A (zh) 2001-07-25
KR20010052766A (ko) 2001-06-25
NO20006282L (no) 2001-02-12
DE69912952T2 (de) 2004-09-02
CA2334730C (en) 2009-09-29
CN1205220C (zh) 2005-06-08
US6583265B1 (en) 2003-06-24
ATE254630T1 (de) 2003-12-15
MXPA00012218A (es) 2002-04-24
PL344599A1 (en) 2001-11-05
DK1086124T3 (da) 2004-03-29
EP1086124B1 (en) 2003-11-19
HUP0102833A3 (en) 2002-03-28
WO1999065933A1 (en) 1999-12-23
JP4477777B2 (ja) 2010-06-09
EP1086124A1 (en) 2001-03-28
ES2212583T3 (es) 2004-07-16
AU4899399A (en) 2000-01-05
HUP0102833A2 (hu) 2002-01-28
DE69912952D1 (en) 2003-12-24
CA2334730A1 (en) 1999-12-23
JP2002518406A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
IL139825A0 (en) Novel cyclosporins
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
GB9914486D0 (en) Medicaments
ZA9711607B (en) Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
DK1109831T3 (da) Cytotoksiske peptider modificeret ved store eller lipofile dele
EP0528312A3 (en) Cyclic peptides and use thereof
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
HUT61780A (en) Process for producing new peptides and pharmaceutical compositions comprising same as active ingredient
MXPA04001968A (es) Agentes antidiabeticos.
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
HK1040237A1 (en) Fused polycyclic amino acids as pharmaceutical agents.
HK1041000B (zh) 新型嘧啶衍生物及其製備方法
WO2001064715A3 (en) Memno peptides, a process for their preparation and their use
IL134194A0 (en) Streptogramines, their preparation and compositions containing them
CA2287991A1 (en) New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments
CA2355720A1 (en) New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
EP1176149A4 (en) NEW GYMNEMIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
CA2338649A1 (en) New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
CA2383114A1 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
CA2385871A1 (en) Ltb4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
CA2396174A1 (en) Aerothricin analogs, their preparation and use